£250m new funding for life sciences

As reported by the EuroBiotechNews,  approximately £250 million of new funding will go into life sciences across the country, a Government minister has announced.

Minister for Universities and Science, David Willetts, announced that £250M has been allocated for the first phase of several five year strategic investment programmes. This includes 26 strategic science programmes and 14 key national research capabilities, to be delivered by eight of the UK’s world-leading bioscience research institutes and their university partners. The process will be led by Britain’s Biotechnology and Biological Sciences Research Council (BBSRC).

Universities and Science Minister David Willetts told MPs during Commons Business questions on Thursday that the investment was a “commitment” to Britain’s bioscience research base. Willetts also said: “This investment will sustain excellent science at some of the UK’s leading institutes and universities. This will drive growth, support highly skilled jobs and keep the UK at the very forefront of bioscience, with benefits ranging from healthcare to energy and global food security.”

Click here to see our latest life science jobs

Follow us on Twitter @CKScienceJobs to receive more industry news and CK jobs of the week updates

 

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , ,

GSK acquire Cellzome for £61 million

The Telegraph have reported that GSK  today, announced that it has entered an agreement to acquire Cellzome for £61 million in which they already own a 20pc stake.

Cellzome is the leader in the development and advancement of proteomics technologies. It currently has labs in Cambridge in the UK and Heidelberg in Germany. GSK currently own 19.98 % equity in the company but they will now assume full control of Cellzome. It will become part of GSK’s R&D organisation.

John Baldoni, senior vice-president of Platform & Technology Science at Glaxo, said: “The acquisition of Cellzome adds significantly to our scientific capabilities and capacity to characterise drug targets, and provides the opportunity to further enhance Glaxo’s ability to bring medicines to patients in a more effective manner.”

Looking for a job in science?

Click here to search our current jobs in science now.

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , ,

Nolato buys British pharmaceutical packaging company Cope Allman Jaycare

Plastics Today reported that Swedish injection molder Nolato has acquired Cope Allman Jaycare, a pharmaceutical packaging company based in the UK

Nolato have bought Cope Allman Jaycare for an initial SEK 179 million (USD $26 million) and a deferred consideration based on earnings up to and including the first quarter of 2014.

Cope Allman Jaycare has a history within pharmaceutical packaging dating back to 1958. The company has 270 employees at its plants in Portsmouth and Newcastle. They have annual sales of around SEK 270 million (USD $39 million), and its customers comprise of a number of international pharmaceutical companies.

Christer Wahlquist, president of Nolato Medical, in a press release said “Nolato already has a strong position in the Scandinavian pharmaceutical packaging market…….This acquisition gives us a local presence in the UK, which is an important part of the global pharmaceutical industry. It also opens doors with a large number of leading international pharmaceutical companies, which are existing customers of Cope Allman Jaycare.”

Click here to see our jobs in the packaging industry

Follow us on Twitter @CKScienceJobs to receive more industry news and CK jobs of the week updates

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , , , , ,